Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3134]

SABCS 2010: High circulating tumour cell levels indicate poor outcome in metastatic breast cancer

SABCS 2010: High circulating tumour cell levels indicate poor outcome in metastatic breast cancer

SABCS 2010: Pertuzumab and trastuzumab combination improved efficacy for women with HER2-positive breast cancer

SABCS 2010: Pertuzumab and trastuzumab combination improved efficacy for women with HER2-positive breast cancer

SABCS 2010: Most US women do not get recommended mammograms

SABCS 2010: Most US women do not get recommended mammograms

SABCS 2010: Obese women with ER-positive/HER2-negative breast cancer have poorer survival rates

SABCS 2010: Obese women with ER-positive/HER2-negative breast cancer have poorer survival rates

SABCS 2010: Aromatase inhibitors increased risk of heart disease in postmenopausal women with breast cancer

SABCS 2010: Aromatase inhibitors increased risk of heart disease in postmenopausal women with breast cancer

Insulin resistance and low adiponectin levels associated with breast cancer mortality

Insulin resistance and low adiponectin levels associated with breast cancer mortality

ASH 2010: No higher incidence of cancer associated with donation of blood stem cells and bone marrow

ASH 2010: No higher incidence of cancer associated with donation of blood stem cells and bone marrow

ASH 2010: Rituximab delays need for chemotherapy in follicular lymphoma

ASH 2010: Rituximab delays need for chemotherapy in follicular lymphoma

ASH 2010: Retuximab for mantle cell lymphoma: European Mantle Cell Lymphoma Network reports

ASH 2010: Retuximab for mantle cell lymphoma: European Mantle Cell Lymphoma Network reports

$ASH 2010: Innovative antibody-drug conjugate offers new hope in relapsed or refractory Hodgkin lymphoma$

ASH 2010: Innovative antibody-drug conjugate offers new hope in relapsed or refractory Hodgkin lymphoma

More from ecancer